Medicover to reach organic revenue exceeding EUR 2.2bn in 2025
The board of directors of Medicover AB (publ) (“Medicover”) has decided on new medium-term financial targets for the three-year period 2023-2025.The new medium-term financial targets confirm the continued intention to maintain robust organic revenue growth alongside sustainable profitability. Inorganic activity will add to the growth and be more weighted to the second half of the target period. · Organic revenue exceeding EUR 2.2 billion in 2025 · Organic adjusted EBITDA in excess of EUR 350 million in 2025 Financial targets related to capital structure and dividend policy